| Mar 31,
2013 | Mar 31,
2014 | Dec 31,
2014 | Dec 31,
2015 | Dec 31,
2016 | Dec 31,
2017 | Dec 31,
2018 | Dec 31,
2019 | Dec 31,
2020 | Dec 31,
2021 | Dec 31,
2022 | Dec 31,
2023 |
|---|
| Profit (loss) before income taxes | 275 | 1,997 | 1,212 | 796 | 355 | 539 | 776 | 861 | 621 | 1,239 | 2,599 | 2,530 |
|---|
| Depreciation | 638 | 805 | 671 | 891 | 761 | 625 | 599 | 717 | 834 | 790 | 865 | 909 |
|---|
| Impairment losses | - | - | - | 14 | 135 | - | - | - | 161 | - | 35 | 18 |
|---|
| Share of loss (profit) of entities accounted for using equity method | 3 | -3 | 0 | -2 | -30 | -11 | -14 | -32 | 12 | 32 | -55 | -3 |
|---|
| Loss (gain) on sale of non-current assets | -12 | -4 | -4 | -3 | -5 | -45 | -13 | -1 | -3 | -12 | -2 | -5 |
|---|
| Loss (gain) on disposal of non-current assets | 30 | 24 | 16 | 38 | 48 | 10 | 33 | 17 | 10 | 16 | 11 | 6 |
|---|
| Loss (gain) on sale of investment securities | - | - | - | - | - | - | - | - | - | - | - | -33 |
|---|
| Subsidy income | - | - | - | - | - | -28 | -25 | -16 | -1 | -27 | -26 | - |
|---|
| Subsidy income | - | - | - | - | - | - | - | - | -235 | -42 | -16 | -18 |
|---|
| Head office transfer cost-OpeCF | - | - | - | - | - | - | - | - | - | - | - | 17 |
|---|
| Loss (gain) on liquidation of subsidiaries and associates | 346 | - | - | - | - | - | - | - | - | -32 | 230 | - |
|---|
| Loss related to infectious disease | - | - | - | - | - | - | - | - | 195 | 45 | 40 | - |
|---|
| Increase (decrease) in allowance for doubtful accounts | 17 | 109 | -24 | -32 | 5 | -49 | 17 | -26 | -4 | -0 | 1 | 5 |
|---|
| Increase (decrease) in provision for bonuses | 31 | 15 | -77 | -2 | -5 | 3 | 12 | 3 | 15 | 8 | -23 | -3 |
|---|
| Increase (decrease) in retirement benefit liability | - | 380 | -2 | 7 | 11 | 7 | 2 | 63 | -8 | 25 | -50 | 48 |
|---|
| Increase (decrease) in provision for bonuses for directors (and other officers) | - | 48 | -28 | -7 | -13 | - | 24 | -24 | - | 15 | 24 | 4 |
|---|
| Increase (decrease) in provision for product repair | - | 301 | -80 | -130 | -23 | -6 | -28 | -23 | -1 | -3 | -4 | 1 |
|---|
| Interest and dividend income | -40 | -49 | -47 | -55 | -50 | -46 | -52 | -54 | -52 | -70 | -80 | -94 |
|---|
| Interest expenses | 140 | 108 | 76 | 112 | 85 | 60 | 72 | 59 | 50 | 38 | 65 | 96 |
|---|
| Decrease (increase) in trade receivables | -1,495 | -609 | -128 | 978 | 488 | 197 | 698 | 319 | 1,153 | -1,356 | -2,011 | 2,634 |
|---|
| Decrease (increase) in inventories | -88 | -73 | 447 | 148 | 577 | -694 | -350 | -701 | 488 | -2,376 | -177 | 451 |
|---|
| Increase (decrease) in trade payables | 208 | 17 | 14 | -922 | -240 | 493 | 31 | -209 | -1,070 | 1,996 | 38 | -1,509 |
|---|
| Other, net | -34 | 12 | -226 | 66 | 168 | -127 | 118 | -194 | 324 | 61 | 72 | 32 |
|---|
| Subtotal | 109 | 2,813 | 1,923 | 1,867 | 2,951 | 967 | 1,913 | 722 | 2,487 | 345 | 1,536 | 5,086 |
|---|
| Interest and dividends received | 39 | 56 | 45 | 129 | 50 | 46 | 52 | 55 | 52 | 70 | 80 | 94 |
|---|
| Interest paid | -134 | -102 | -73 | -106 | -89 | -61 | -75 | -61 | -51 | -39 | -64 | -97 |
|---|
| Subsidies received | - | - | - | - | - | 28 | 16 | 16 | 1 | 27 | 26 | - |
|---|
| Subsidies received | - | - | - | - | - | - | - | - | 214 | 64 | 16 | 18 |
|---|
| Payments for head office relocation expenses | - | - | - | - | - | - | - | - | - | - | - | -16 |
|---|
| Payment of loss related to infectious disease | - | - | - | - | - | - | - | - | -192 | -36 | -36 | - |
|---|
| Income taxes paid | -206 | -400 | -829 | -238 | -422 | -273 | -158 | -133 | -230 | -251 | -200 | -636 |
|---|
| Net cash provided by (used in) operating activities | -190 | 2,366 | 1,066 | 1,652 | 2,388 | 642 | 1,728 | 558 | 2,289 | 181 | 1,357 | 4,449 |
|---|
| Purchase of property, plant and equipment | -624 | -804 | -446 | -623 | -454 | -519 | -516 | -606 | -583 | -730 | -682 | -964 |
|---|
| Proceeds from sale of property, plant and equipment | 72 | 192 | 23 | 236 | 298 | 71 | 95 | 11 | 6 | 26 | 13 | 3 |
|---|
| Purchase of investment securities | -360 | -446 | -208 | -107 | -4 | -4 | -5 | -4 | -99 | -107 | -7 | -119 |
|---|
| Proceeds from sale of investment securities | - | 451 | 439 | 156 | 150 | - | - | 202 | - | - | - | 99 |
|---|
| Purchase of shares of subsidiaries and associates | -47 | - | - | - | - | - | - | - | - | - | -227 | - |
|---|
| Other, net | -276 | -160 | -4 | -104 | -86 | -85 | -151 | -248 | -97 | -73 | -167 | -42 |
|---|
| Net cash provided by (used in) investing activities | -748 | -567 | -197 | -441 | -97 | -509 | -577 | -646 | -774 | -884 | -1,070 | -1,022 |
|---|
| Net increase (decrease) in short-term borrowings | -1,360 | -93 | -559 | -66 | -263 | 317 | -614 | 82 | 210 | -264 | 555 | -1,509 |
|---|
| Proceeds from long-term borrowings | 5,192 | 1,801 | 446 | 1,661 | 500 | 100 | 832 | 526 | 602 | 603 | 558 | 1,110 |
|---|
| Repayments of long-term borrowings | -3,109 | -2,710 | -1,375 | -2,163 | -1,798 | -2,689 | -630 | -385 | -378 | -328 | -409 | -1,601 |
|---|
| Purchase of treasury shares | -0 | - | -0 | - | - | - | - | -155 | -0 | -0 | -0 | -0 |
|---|
| Dividends paid | -94 | -94 | -125 | -125 | -125 | -125 | -125 | -138 | -134 | -146 | -195 | -366 |
|---|
| Dividends paid to non-controlling interests | - | - | - | -23 | -32 | -31 | -28 | - | - | - | -13 | -14 |
|---|
| Other, net | -6 | -46 | -27 | -52 | -43 | -65 | -34 | -142 | -194 | -153 | -137 | -133 |
|---|
| Net cash provided by (used in) financing activities | 24 | -1,170 | -1,648 | -769 | -1,789 | -2,493 | -599 | -287 | 106 | -602 | 359 | -2,512 |
|---|
| Effect of exchange rate change on cash and cash equivalents | 349 | 644 | 354 | -138 | -260 | 51 | -108 | -41 | 12 | 293 | 162 | 187 |
|---|
| Net increase (decrease) in cash and cash equivalents | -565 | 1,274 | -425 | 304 | 242 | -2,309 | 444 | -415 | 1,633 | -1,012 | 808 | 1,103 |
|---|
| Increase in cash and cash equivalents resulting from inclusion of subsidiaries in consolidation | - | - | - | 189 | - | - | - | - | - | - | - | 221 |
|---|